Comparison of Long-Term Outcome between Imatinib and Dasatinib Prophylaxis after Allogeneic Stem Cell Transplantation in Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia-a Multi-Center Retrospective Study

doi:10.1182/blood-2023-184478

科研成果详情

题名	Comparison of Long-Term Outcome between Imatinib and Dasatinib Prophylaxis after Allogeneic Stem Cell Transplantation in Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia-a Multi-Center Retrospective Study
作者	Guan, Fangshu 1; Yang, Luxin 2; Zhu, Panpan 3; Lai, Xiaoyu 2; Liu, Lizhen 2; Shi, Jimin 2; Zhao, Yanmin 2; Yu, Jian 2; Fu, Huarui 2; Zhao, Yi 2; Lan, Jianping 4; Chen, Yi5; Lu, Ying 6; Ouyang, Guifang 7; Xu, Yang 8; Qiu, Xi 9; Cai, Zhen 2; Huang, He 2; Luo, Yi 2
会议录名称	BLOOD 影响因子和分区
语种	英语
原始文献类型	Meeting Abstract
会议名称	65th Annual Meeting of the American-Society-of-Hematology (ASH)
会议日期	DEC 09-12, 2023
会议地点	San Diego, CA
出版地	WASHINGTON
ISSN	0006-4971
EISSN	1528-0020
DOI	10.1182/blood-2023-184478
页数	3
WOS类目	Hematology
WOS研究方向	Hematology
WOS记录号	WOS:001159900807129
收录类别	SCIE ; CPCI ; CPCI-S
发表日期	2023-11-02
引用统计
文献类型	会议论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/210069
专题	附属第一医院_血液内科
作者单位	1.Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China; 2.Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Peoples R China; 3.Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Peoples R China; 4.Zhejiang Prov Peoples Hosp, Hangzhou, Peoples R China; 5.Wenzhou Med Univ, Affiliated Hosp 1, Dept Hematol, Wenzhou, Peoples R China; 6.Yinzhou Peoples Hosp, Dept Hematol, Ningbo, Peoples R China; 7.Ningbo First Hosp, Dept Hematol, Ningbo, Peoples R China; 8.Soochow Univ, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Collaborat Innovat Ctr Hematol,Affiliated Hosp 1, Hangzhou, Peoples R China; 9.Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Peoples R China
推荐引用方式 GB/T 7714	Guan, Fangshu,Yang, Luxin,Zhu, Panpan,et al. Comparison of Long-Term Outcome between Imatinib and Dasatinib Prophylaxis after Allogeneic Stem Cell Transplantation in Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia-a Multi-Center Retrospective Study[C]. WASHINGTON,2023.